Literature DB >> 17508727

The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units.

Brian M Dattilo1, Günter Fritz, Estelle Leclerc, Craig W Vander Kooi, Claus W Heizmann, Walter J Chazin.   

Abstract

The receptor for advanced glycation end products (RAGE) is an important cell surface receptor being pursued as a therapeutic target because it has been implicated in complications arising from diabetes and chronic inflammatory conditions. RAGE is a single membrane spanning receptor containing a very small approximately 40 residue cytosolic domain and a large extracellular region composed of 3 Ig-like domains. In this study, high level bacterial expression systems and purification protocols were generated for the extracellular region of RAGE (sRAGE) and the five permutations of single and tandem domain constructs to enable biophysical and structural characterization of its tertiary and quaternary structure. The structure and stability of each of these six protein constructs was assayed by biochemical methods including limited proteolysis, dynamic light scattering, CD, and NMR. A homology model of sRAGE was constructed to aid in the interpretation of the experimental data. Our results show that the V and C1 domains are not independent domains, but rather form an integrated structural unit. In contrast, C2 is attached to VC1 by a flexible linker and is fully independent. The interaction with a known RAGE ligand, Ca2+-S100B, was mapped to VC1, with the major contribution from the V domain but clearly defined secondary effects from the C1 domain. The implications of these results are discussed with respect to models for RAGE signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17508727      PMCID: PMC2527459          DOI: 10.1021/bi7003735

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  66 in total

1.  Crystal structure of a T cell receptor Valpha11 (AV11S5) domain: new canonical forms for the first and second complementarity determining regions.

Authors:  M Machius; P Cianga; J Deisenhofer; E S Ward
Journal:  J Mol Biol       Date:  2001-07-20       Impact factor: 5.469

2.  Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.

Authors:  A Taguchi; D C Blood; G del Toro; A Canet; D C Lee; W Qu; N Tanji; Y Lu; E Lalla; C Fu; M A Hofmann; T Kislinger; M Ingram; A Lu; H Tanaka; O Hori; S Ogawa; D M Stern; A M Schmidt
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

3.  The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site.

Authors:  Katsuya Ishihara; Kae Tsutsumi; Shiho Kawane; Motowo Nakajima; Tatsuhiko Kasaoka
Journal:  FEBS Lett       Date:  2003-08-28       Impact factor: 4.124

Review 4.  Monitoring of S100 homodimerization and heterodimeric interactions by the yeast two-hybrid system.

Authors:  Jean Christophe Deloulme; Benoît Jean Gentil; Jacques Baudier
Journal:  Microsc Res Tech       Date:  2003-04-15       Impact factor: 2.769

Review 5.  The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.

Authors:  O Hori; S D Yan; S Ogawa; K Kuwabara; M Matsumoto; D Stern; A M Schmidt
Journal:  Nephrol Dial Transplant       Date:  1996       Impact factor: 5.992

6.  The program XEASY for computer-supported NMR spectral analysis of biological macromolecules.

Authors:  C Bartels; T H Xia; M Billeter; P Güntert; K Wüthrich
Journal:  J Biomol NMR       Date:  1995-07       Impact factor: 2.835

7.  Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE).

Authors:  Lana E Hanford; Jan J Enghild; Zuzana Valnickova; Steen V Petersen; Lisa M Schaefer; Todd M Schaefer; Todd A Reinhart; Tim D Oury
Journal:  J Biol Chem       Date:  2004-09-20       Impact factor: 5.157

Review 8.  Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.

Authors:  S Yamagishi; M Takeuchi; Y Inagaki; K Nakamura; T Imaizumi
Journal:  Int J Clin Pharmacol Res       Date:  2003

9.  Expression and purification of recombinant human receptor for advanced glycation endproducts in Escherichia coli.

Authors:  Rosemarie Wilton; Mohammed A Yousef; Poonam Saxena; Mercedes Szpunar; Fred J Stevens
Journal:  Protein Expr Purif       Date:  2006-02-08       Impact factor: 1.650

10.  The adhesive and neurite-promoting molecule p30: analysis of the amino-terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons.

Authors:  H Rauvala; J Merenmies; R Pihlaskari; M Korkolainen; M L Huhtala; P Panula
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

View more
  68 in total

1.  The G82S polymorphism promotes glycosylation of the receptor for advanced glycation end products (RAGE) at asparagine 81: comparison of wild-type rage with the G82S polymorphic variant.

Authors:  Sun Jin Park; Torsten Kleffmann; Paul A Hessian
Journal:  J Biol Chem       Date:  2011-04-21       Impact factor: 5.157

2.  Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction.

Authors:  Hongliang Zong; Angelina Madden; Micheal Ward; Mark H Mooney; Christopher T Elliott; Alan W Stitt
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

Review 3.  Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer.

Authors:  Geetha Srikrishna; Hudson H Freeze
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

4.  Relating form and function of EF-hand calcium binding proteins.

Authors:  Walter J Chazin
Journal:  Acc Chem Res       Date:  2011-02-11       Impact factor: 22.384

5.  Advanced glycation end product recognition by the receptor for AGEs.

Authors:  Jing Xue; Vivek Rai; David Singer; Stefan Chabierski; Jingjing Xie; Sergey Reverdatto; David S Burz; Ann Marie Schmidt; Ralf Hoffmann; Alexander Shekhtman
Journal:  Structure       Date:  2011-05-11       Impact factor: 5.006

6.  S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release.

Authors:  Roberta Bianchi; Eirini Kastrisianaki; Ileana Giambanco; Rosario Donato
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

7.  Change in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling.

Authors:  Jing Xue; Michaele Manigrasso; Matteo Scalabrin; Vivek Rai; Sergey Reverdatto; David S Burz; Daniele Fabris; Ann Marie Schmidt; Alexander Shekhtman
Journal:  Structure       Date:  2016-08-11       Impact factor: 5.006

8.  The S100B/RAGE Axis in Alzheimer's Disease.

Authors:  Estelle Leclerc; Emmanuel Sturchler; Stefan W Vetter
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-21

Review 9.  The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Expert Rev Mol Med       Date:  2009-03-12       Impact factor: 5.600

10.  Stable RAGE-heparan sulfate complexes are essential for signal transduction.

Authors:  Ding Xu; Jeffrey H Young; Juno M Krahn; Danyin Song; Kevin D Corbett; Walter J Chazin; Lars C Pedersen; Jeffrey D Esko
Journal:  ACS Chem Biol       Date:  2013-05-28       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.